Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SGMO...58...🥳...on the Upper Bollie Break...
georgie18
Member Level
Re: georgie18 post# 1012
Tuesday, June 03, 2025 10:47:06 AM
Post#
1017
of 1023
SGMO...5137...🥳...Bullish Psar flip coming off the .45 range bottom...
They have a 30 year history of failures and pivots. Also, PFE, GILD, SNY, NVS and BIIB all ditched the partnerships with them. Fabry seems to be the last chance to prove that they can actually complete and deliver a therapy. Everything else is (mostly) talk.
That it is...🥳...but one day it will take off...
Well, It's a good swing trade stock with frequent tradeable volatility
I been playing it for years…🥳
$SGMO ~ I've been covering this since May 15 with suggestion of .46 Limit entry for my private email followers.
It's hit .55 area so far this morning. Next week could be a fun week.
...And $ONCY is next soon to turn upward from low. 30s currently
SGMO chart:
https://stockcharts.com/c-sc/sc?s=SGMO&p=D&yr=0&mn=5&dy=15&i=p22152625358&r=1747767875225
SGMO...5137...🥳...Bullish Psar flip coming off the .45 range bottom...
That's a typical short sided statement. Eli Lily thinks it's worthy so me too.
Just bot at .46
The company looks pretty much done for. They are starting to put nails in the coffin.
$SGMO .82 Coming back up nicely with the market ... .
SGMO...749...🥳...Been adding the .60 range dip to my .90s...Market finally reacting to Lilly News...
georgie18
Member Level
Re: None
Thursday, April 03, 2025 7:52:22 PM
Post#
678758
of 679354
SGMO...92...🥳...https://www.businesswire.com/news/home/20250403023818/en/Sangamo-Therapeutics-Announces-Capsid-License-Agreement-With-Lilly-to-Deliver-Genomic-Medicines-for-Diseases-of-the-Central-Nervous-System
Wow, $18 million upfront! How long will that last?! With no milestones, they will need additional deals.
Back up to a buck after the market settles ...
Enjoy the weekend >> M
SGMO.......................................................................a/h
$SGMO > Shorts riding this pretty hard ... Oversold yet ?
SGMO...$1.30...🥳...Off my $1.22 Alert...https://www.businesswire.com/news/home/20250206513390/en/
georgie18
Member Level
Re: georgie18 post# 1002
Friday, January 31, 2025 9:37:17 AM
Post#
1003
of 1003
SGMO...$1.27...🥳...on the Bollie Squeeze...Open Gap in the $2 range...
georgie18
Member Level
Re: None
Thursday, January 30, 2025 2:13:23 PM
Post#
31218
of 31261
SGMO...$1.22... https://schrts.co/IqItbIfD ...Bollie Squeeze setting up here...🥳
SGMO...$1.27...🥳...on the Bollie Squeeze...Open Gap in the $2 range...
georgie18
Member Level
Re: None
Thursday, January 30, 2025 2:13:23 PM
Post#
31218
of 31261
SGMO...$1.22... https://schrts.co/IqItbIfD ...Bollie Squeeze setting up here...🥳
SGMO...$1.22... https://schrts.co/IqItbIfD ...Bollie Squeeze setting up here...🥳
SGMO...$1.45...🥳...Off my $1.03 Dip Alert...
georgie18
Member Level
Re: georgie18 post# 670316
Monday, January 06, 2025 9:52:15 AM
Post#
670503
of 670675
SGMO...$1.35s clearing here off my $1.03 Dip Alert...🥳
georgie18
Member Level
Re: georgie18 post# 996
Friday, January 03, 2025 2:29:51 PM
Post#
997
of 999
SGMO...$1.28s clearing here...🥳...Off the $1.03...Dip Alert...
georgie18
Member Level
Re: georgie18 post# 670026
Friday, January 03, 2025 8:31:17 AM
Post#
670182
of 670314
SGMO...$1.13s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 985
Thursday, January 02, 2025 9:42:07 AM
Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
SGMO...$1.35s clearing here off my $1.03 Dip Alert...🥳
georgie18
Member Level
Re: georgie18 post# 996
Friday, January 03, 2025 2:29:51 PM
Post#
997
of 999
SGMO...$1.28s clearing here...🥳...Off the $1.03...Dip Alert...
georgie18
Member Level
Re: georgie18 post# 670026
Friday, January 03, 2025 8:31:17 AM
Post#
670182
of 670314
SGMO...$1.13s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 985
Thursday, January 02, 2025 9:42:07 AM
Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
SGMO...$1.28s clearing here...🥳...Off the $1.03...Dip Alert...
georgie18
Member Level
Re: georgie18 post# 670026
Friday, January 03, 2025 8:31:17 AM
Post#
670182
of 670314
SGMO...$1.13s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 985
Thursday, January 02, 2025 9:42:07 AM
Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
SGMO...$1.13s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 985
Thursday, January 02, 2025 9:42:07 AM
Post#
992
of 995
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
nice year end gift to the shareholders! LOL
mind you Roche and Pfizer both shredded their AAV hem a compounds
Its when they give no roadmap!
instead tout the present - everyone knows
bios run TOWARDS events
SGMO...$1.03...🥳...Loading down here...Took a dip... Pfizer terminated partnership...
Way under
Maybe a (future) trade for Fabry, but that’s it!
If I've ever seen an over reaction and a buying opportunity before this is Olympic!
New 52wk highs coming soon
SGMO...$2.87...🥳Looking for the $3 Breakout...Last run from .30 to $3...
georgie18
Member Level
Re: None
Friday, December 13, 2024 9:33:14 AM
Post#
980
of 984
SGMO...$2.11...Starting up again...🥳
SGMO...$2.66...🥳...on the Breakout...
SGMO...$2.50...🥳...Trying for Upper Bollie Breakout here...
Career site shows just 2 temporary positions for weeks?
Maybe has momo till december 9 presentation of the ph3 in HEM A with Pfizer.
May go to 4 first but valuation makes no sense - overbought zinc finger dud.
Smart and extensive promotion campaign by management.
SGMO - Nice day and the start of another uptrend
Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
BUSINESS WIRE 4:15 PM ET 11/19/2024
Followers
|
88
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1024
|
Created
|
09/09/04
|
Type
|
Free
|
Moderators |
http://www.sangamo.com/index.php
http://finance.yahoo.com/q/ks?s=SGMO+Key+Statistics
Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. The company?s proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome editing and gene regulation. The ZFPs could be engineered to make ZFP nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off. Its therapeutic products include SB-728-T, a ZFN-mediated autologous T-cell product for human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I clinical trials; and SB-728-HSPC that is in Phase I/II clinical trials for HIV/AIDS. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B, Hemophilia A, and Mucopolysaccharidosis I (MPS) and MPS II, which are lysosomal storage disorder (LSD); proprietary preclinical programs in other LSDs; and research stage programs in certain central nervous system disorders and cancer immunotherapies. It has collaborative partnerships with Biogen Inc. to develop therapeutic genome editing products in hemoglobinopathies; and with Shire International GmbH to develop the preclinical development program in Huntington?s disease, as well as license agreement with Sigma-Aldrich Corporation to develop ZFP-based laboratory research reagents and Dow AgroSciences, LLC to modify the genomes or alter protein expression of plant cells, plants, or plant cell cultures. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Richmond, California.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |